Clinical Evaluation of Punarnavadi Madura and Dadimadi Ghrita in the Management of Iron Deficiency Anaemia - ACT- IDA-2010

Department of AYUSH Ministry of Health Family Welfare Government of India0 个研究点目标入组 150 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Children of either sex aged between 10 to 14 years
•2. Children with iron deficiency anemia (Hb 8gm-10gm.%),
•3. Willing and able to participate for 16 weeks. (Assent to be obtained from Parent(s) / Guardian(s).

•1. Children suffering from major systemic illness necessitating long term drug treatment.
•2. Children with evidence of malignancy.
•3. Children with concurrent serious Hepatic Dysfunction (defined as AST and/or ALT 3 times of the upper normal limit) or Renal Dysfunction (defined as S. creatinine 1.2mg/dl) Uncontrolled Pulmonary Dysfunction (asthmatic and COPD patients)
•4. Co-morbidities like Tuberculosis, Chronic urinary tract infection, Bleeding disorders etc.
•5. H/o hypersensitivity to any of the trial drugs or their ingredients.
•6. Children who have completed participation in any other clinical trial during the past six (06) months.
•7. Any other condition which the P.I. thinks may jeopardize the study

发起方

Department of AYUSH Ministry of Health Family Welfare Government of India